Prestige Consumer Healthc... (PBH)
Bid | 82.27 |
Market Cap | 4.08B |
Revenue (ttm) | 1.12B |
Net Income (ttm) | 213.94M |
EPS (ttm) | 4.26 |
PE Ratio (ttm) | 19.33 |
Forward PE | 16.63 |
Analyst | Buy |
Ask | 82.38 |
Volume | 233,826 |
Avg. Volume (20D) | 365,781 |
Open | 82.69 |
Previous Close | 82.12 |
Day's Range | 81.19 - 82.69 |
52-Week Range | 62.35 - 90.04 |
Beta | 0.47 |
About PBH
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, ...
Analyst Forecast
According to 5 analyst ratings, the average rating for PBH stock is "Buy." The 12-month stock price forecast is $98.5, which is an increase of 19.61% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

2 months ago · seekingalpha.com
Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call TranscriptPrestige Consumer Healthcare Inc. (NYSE:PBH ) Q3 2025 Results Conference Call February 6, 2025 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chair...